Lab
Laboratorio Clinico Del Centro
Laboratorio Clinico Del Centro was paid $662K by Medicaid between Jan 2018 and Nov 2024, across 38 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 13% of everything it billed.
33Billing provider infoLABORATORIO CLINICO DEL CENTRO
FLORIDA, PR 00650
FLORIDA, PR 00650
33aNPI1245211218assigned 11/08/2005
33bProvider typeClinical Medical Laboratory
28Total paid$662K
24GClaims63,457
24DCodes billed38
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#201 of 777
Median peer was paid$278K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,068 | $70K | |
| 2019 | 7,187 | $55K | |
| 2020 | 4,350 | $34K | |
| 2021 | 10,405 | $142K | |
| 2022 | 11,491 | $166K | |
| 2023 | 10,677 | $101K | |
| 2024incomplete | 10,279 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 13% | 5,966 | 5,577 | $89K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 12% | 1,936 | 1,789 | $79K |
| 80061 | Lipid panel | 11% | 5,731 | 5,378 | $69K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 9.7% | 2,679 | 2,387 | $64K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 8.7% | 8,436 | 7,741 | $58K |
| 80053 | Comprehensive metabolic panel | 8.5% | 6,044 | 5,604 | $56K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7.3% | 1,802 | 1,676 | $48K |
| 86328 | 3.9% | 837 | 742 | $26K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.9% | 2,909 | 2,733 | $26K |
| 36415 | Collection of venous blood by venipuncture | 3.4% | 8,864 | 7,997 | $23K |
| 81000 | 2.8% | 6,545 | 6,097 | $19K | |
| 82274 | 2.3% | 1,039 | 961 | $15K |
26 more codes
| 86701 | 1.4% | 1,057 | $10K | |
| 82607 | 1.3% | 651 | $9K | |
| 87276 | 1.0% | 547 | $7K | |
| 82043 | 1.0% | 1,214 | $7K | |
| 87275 | 1.0% | 546 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.0% | 862 | $7K |
| 86738 | <1% | 502 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 126 | $6K |
| 84153 | <1% | 353 | $6K | |
| 87088 | <1% | 758 | $6K | |
| 86592 | <1% | 974 | $4K | |
| 82570 | <1% | 715 | $3K | |
| 85651 | <1% | 914 | $3K | |
| 84439 | <1% | 278 | $3K | |
| 84436 | <1% | 420 | $2K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 41 | $2K |
| 84479 | <1% | 353 | $2K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 41 | $819.07 |
| 80076 | <1% | 80 | $616.04 | |
| 85027 | <1% | 81 | $446.79 | |
| 86038 | <1% | 19 | $219.14 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 26 | $205.33 |
| 86140 | <1% | 41 | $156.51 | |
| 80050 | General health panel | <1% | 14 | $134.98 |
| 82270 | <1% | 44 | $114.55 | |
| 86431 | <1% | 12 | $62.19 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTOLDEO, ILIA (LAB SUPERVISOR)